168 related articles for article (PubMed ID: 22800891)
1. Discovery and identification of serum biomarkers of Wilms' tumor in mice using proteomics technology.
Jia ZK; Wang JX; Yang JJ; Xue R; Zhang D; Wang GN; Ma SL; Duan ZF
Chin Med J (Engl); 2012 May; 125(10):1727-32. PubMed ID: 22800891
[TBL] [Abstract][Full Text] [Related]
2. Screening and identification of non-inflammatory specific protein markers in Wilms' tumor tissues.
Zhang J; Guo F; Wang L; Zhao W; Zhang D; Yang H; Yu J; Niu L; Yang F; Zheng S; Wang J
Arch Biochem Biophys; 2019 Nov; 676():108112. PubMed ID: 31550443
[TBL] [Abstract][Full Text] [Related]
3. [Screening and identification analysis of serum protein biomarkers in nephroblastoma].
Wang JX; Yang SB; Liu QL; Dong R; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1259-63. PubMed ID: 19595180
[TBL] [Abstract][Full Text] [Related]
4. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
5. Detection of biomarkers in children with Wilms' tumor using proteinchip technology.
Zhang Q; Shan Y; Wang JX; Dong R; Yang SB; Zheng S
Chin Med J (Engl); 2010 Jul; 123(14):1939-41. PubMed ID: 20819581
[No Abstract] [Full Text] [Related]
6. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
7. Identification of serum protein biomarkers in biliary atresia by mass spectrometry and enzyme-linked immunosorbent assay.
Song Z; Dong R; Fan Y; Zheng S
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):370-5. PubMed ID: 22569524
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel serum biomarkers in child nephroblastoma using proteomics technology.
Zhang Q; Wang J; Dong R; Yang S; Zheng S
Mol Biol Rep; 2011 Jan; 38(1):631-8. PubMed ID: 20369385
[TBL] [Abstract][Full Text] [Related]
9. [Detecting biomarkers from serum in nephroblastoma patients with support vector machine].
Wang JX; Zhang J; Liu QL; Wang L; Fan YZ; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2982-5. PubMed ID: 17288811
[TBL] [Abstract][Full Text] [Related]
10. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
[TBL] [Abstract][Full Text] [Related]
11. Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma.
Dowdy SF; Weissman BE; Stanbridge EJ
J Cell Physiol; 1991 May; 147(2):248-55. PubMed ID: 1645741
[TBL] [Abstract][Full Text] [Related]
12. Kidney protein profiling of Wilms' tumor patients by analysis of formalin-fixed paraffin-embedded tissue samples.
Hammer E; Ernst FD; Thiele A; Karanam NK; Kujath C; Evert M; Völker U; Barthlen W
Clin Chim Acta; 2014 Jun; 433():235-41. PubMed ID: 24680863
[TBL] [Abstract][Full Text] [Related]
13. Adult Wilms' tumor: review of literature.
Ali EM; Elnashar AT
J Oncol Pharm Pract; 2012 Mar; 18(1):148-51. PubMed ID: 21248171
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model.
Abramson LP; Stellmach V; Doll JA; Cornwell M; Arensman RM; Crawford SE
J Pediatr Surg; 2003 Mar; 38(3):336-42; discussion 336-42. PubMed ID: 12632345
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
[TBL] [Abstract][Full Text] [Related]
17. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
[TBL] [Abstract][Full Text] [Related]
18. Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor.
Rong Y; Cheng L; Ning H; Zou J; Zhang Y; Xu F; Liu L; Chang Z; Fu XY
Cancer Res; 2006 Aug; 66(16):8049-57. PubMed ID: 16912181
[TBL] [Abstract][Full Text] [Related]
19. Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells.
Fraizer GE; Bowen-Pope DF; Vogel AM
J Cell Physiol; 1987 Oct; 133(1):169-74. PubMed ID: 2444606
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
